The move intensifies the competition with Eli Lilly, which secured approval for its weight loss drug in China in July but has ...
European mega-caps trail US 'Magnificent 7' amid lack of AI gains, while also facing China’s slowdown and rising geopolitical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback